Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...
Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says.
An investigational antibody demonstrated an ability to preserve vision in people with geographic atrophy from dry age-related ...
Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...
Age-related macular degeneration (AMD) is one of the leading causes of vision ... Since AMD is closely linked with aging, some researchers have turned their attention to metformin—a drug better known ...
A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...
Roche has released positive topline one-year findings from a Phase IV trial of Vabysmo (faricimab) to treat diabetic macular ...
MedPage Today on MSN3d
Approval of Bevacizumab Biosimilar Could Eliminate Access to Low-Cost AMD TherapyCHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...
Novo Nordisk asked the FDA to bar compounding pharmacies from making semaglutide, arguing it is too complex for the ...
By squeezing Regeneron’s Eylea, eye disease drug Vabysmo has become one of the biggest growth drivers for Roche. | Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback